Skip to content
January 31, 2025

Investment information for the new generation

Search

CTSO.Q

CytoSorbents (CTSO.Q) has been awarded a three-year contract valued at $4,421,487 to complete a preclinical development of the HemoDefend plasma and whole blood adsorber by the assistant Secretary of…